Keros Therapeutics (KROS) Insider Trading & Ownership $13.98 +0.24 (+1.71%) As of 01:13 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics (NASDAQ:KROS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$9.46MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$11.00M Get KROS Insider Trade Alerts Want to know when executives and insiders are buying or selling Keros Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KROS Insider Buying and Selling by Quarter Keros Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/9/2025Adar1 Capital Management, LlcMajor ShareholderBuy934,258$10.13$9,464,033.54 8/13/2024Carl L GordonDirectorSell250,000$44.01$11,002,500.00 (Data available from 1/1/2013 forward) KROS Insider Trading Activity - Frequently Asked Questions Who is on Keros Therapeutics' Insider Roster? The list of insiders at Keros Therapeutics includes Adar1 Capital Management, Llc, Carl L Gordon, and Keith Regnante. Learn more on insiders at KROS. What percentage of Keros Therapeutics stock is owned by insiders? 22.90% of Keros Therapeutics stock is owned by insiders. Learn more on KROS's insider holdings. Which Keros Therapeutics insiders have been buying company stock? The following insider purchased KROS shares in the last 24 months: Adar1 Capital Management, Llc ($9,464,033.54). How much insider buying is happening at Keros Therapeutics? Insiders have purchased a total of 934,258 KROS shares in the last 24 months for a total of $9,464,033.54 bought. Which Keros Therapeutics insiders have been selling company stock? The following insider sold KROS shares in the last 24 months: Carl L Gordon ($11,002,500.00). How much insider selling is happening at Keros Therapeutics? Insiders have sold a total of 250,000 Keros Therapeutics shares in the last 24 months for a total of $11,002,500.00 sold. Keros Therapeutics Key ExecutivesDr. Jasbir S. Seehra Ph.D. (Age 68)President, CEO & Director Compensation: $1.13MMr. Keith C. Regnante MBA (Age 54)Chief Financial Officer Compensation: $636.11kMr. Christopher Rovaldi M.Sc. (Age 49)Chief Operating Officer Compensation: $784.9kMs. Esther Cho J.D.Senior VP, General Counsel & SecretaryMs. Robin WagnerSenior Vice President of Human ResourcesMr. John Oram M.B.A.Senior Vice President of Program & Portfolio Management More Insider Trading Tools from MarketBeat Related Companies AGIO Insider Transactions RXRX Insider Transactions TWST Insider Transactions SRPT Insider Transactions DNLI Insider Transactions CNTA Insider Transactions KNSA Insider Transactions CGON Insider Transactions BEAM Insider Transactions IRON Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealth This page (NASDAQ:KROS) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
